Upcoming Allied Market Research
Cancer Stem Cells Market

Cancer Stem Cells Market: Global Opportunity Analysis and Industry Forecast, 2022-2029

Pages: NA
Jul 2022 | 751 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cancer Stem Cells Market

Request Now !

Cancer stem cells (CSCs) or cancer initiating cells are a discount population of cells that exhibit distinctive self-renewal, proliferation, and differentiation capabilities that are believed to play a critical role in cancer initiation, maintenance, progression, drug resistance, and cancer recurrence or metastasis. Various cell surface markers such as CD44, CD24, and CD133 are often used to identify and enrich CSCs. While a regulatory network consisting of microRNAs, Notch and Hedgehog signaling pathways controls the CSC properties. The clinical relevance of CSCs has been proven by emerging evidence, explaining that CSCs are resistant to conventional radiation treatment and chemotherapy. They are believed to be an important target for novel anti-cancer drug discovery, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

The fatality rate of cancer has been on a rise globally. Hence various major players in cancer stem cells are investing money and funding associated R&D activity to get a breakthrough for treatment of cancer. Existing cancer treatment studies have mostly been developed carried on animal based models, where therapies able to promote tumor shrinkage were seen effective. However, animals do not provide a complete model of progression and mechanism of human disease.

COVID – 19 scenario analysis:  

  • Due to the ongoing COVID – 19 pandemic, with more than to four million infections and the economies showing signs of the 2008 financial crisis, COVID-19 has impacted several industries including cancer stem cells market as well
  • One of the key concerns looming across the cancer stem cell industry is the lack of optimum vector manufacturing capacity
  • The ongoing COVID-19 pandemic and the after lashes of lockdown in various countries throughout across the globe is likely to pressurize the vector manufacturers to meet the future demand for cancer cell therapies
  • The stem cell manufacturing market is in development stages and the manufacturers are trying to find better solutions to the ongoing challenges
  • However, the pandemic may likely push the players in the market to accelerate the development of these solutions in coming are 3-4 months phase, we could expect a stronger and more structured industry

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Pouring of funds into R&D activities and government initiatives to boost research related to cancer, successful ventures in clinical oncology, improved survival rate of patients, and increase in transplantation procedures are considered as major factors responsible for fueling growth in the cancer stem cell market. On the contrary, inequality issues coupled with diagnosis and expensive cell therapy treatments through stem cell treatment is significantly hampering the growth of cancer stem cells market. High cost cell therapies & stringent regulations reducing market growth. 

According to CBC Canada, cancer stem cell treatment per person costs around $ 5,000 to $ 8,000 and can reach as high as $ 25000. Hence, economic issues among the population, middle class and lower middle class sector of people would be unable to afford and accept this technology creating hindrances for the Cancer stem cells market growth.

Rising prevalence of cancer and increasing number of patients

According to the Cancer Research UK, around 17 million cancer cases were registered in 2018, out of which 56% of the cases were fatal. There are many key factors that may affect the success rate of chemo and radiation therapy and a person's survival rate such as age, overall health and cancer stage. As per a research report by the World Health Organization (WHO), in low- and middle-income countries, around 70% of deaths occurs due to cancer. Poor food habits, changing lifestyle, increase in of smoking habits, genetic mutation, alcohol and hormones consumption, urban air pollution are the frequent reasons for the increasing number of cancer patients in the world. Rising number of cancer across the globe is proving to be significant for boosting the growth of cancer stem cells market.

Technological advances in cancer stem cells

The cancer stem cells (CSCs) research is aiding healthcare professionals gain insights into CSCs biology and their signaling pathways. Significant improvements in experimental approaches, particularly, in vitro assay systems have enabled scientists to record the relationship between different cell types in a tumor.  This has helped develop a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing better clinical outcome for the patient. The National Cancer Institute projects that nearly five million more U.S. citizens are expected to survive various types of cancer in 2026, as compared to 2016.Nov 2015 saw Merck introduce the new AldeRed ALDH Detection Kit for identifying and isolating cancer stem cells which would help the growth of cancer stem cells market. Tel Aviv University, recently engineered advanced biosensor which can target leukemic stem cells. With this, the researchers are expecting to reduce the chances of relapse in blood cancer by targeting malignant leukemic stem cells. 

Turkey is emerging as a hotspot for stem cells in Europe as Stem cell research is the fast growing medical practice owing to factors such as hospitality, modern laboratory equipment as well as 'high quality, low cost stem cell treatment', creating lucrative market for stem cells investors. In order to improve the healthcare facilities in the country, the Japanese government is heavily investing in cancer treatment and related research which will surge the growth in cancer stem cells treatment market in Japan

Key benefits of the report:

  • This study presents the analytical depiction of the global cancer stem cells industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Cancer stem cells market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global cancer stem cells market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Cancer stem cells market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cancer Stem Cells Market research report:

  • Who are the leading market players active in the cancer stem cells market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

Key Market Segments

Segments Sub-segments
By Mode of Action
  • Stem cell based cancer therapy
  • Targeted cancerous stem cells
  • Autologous SC transplant
  • Allogeneic SC transplant
By Type
  • Breast cancer
  • Lung cancer
  • Blood cancer
  • Brain cancer
  • Colorectal cancer
  • Others
By End User
  • Specialised cancer treatment centers
  • Hospitals
  • Research institutes and labs
By Region
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • rest of Asia-Pacific
    • Brazil
    • South Arabia
    • South Africa
    • rest of LAMEA

Key Market Players

  • Merck KGaA
  • Bionomics
  • Thermo Fisher Scientific Inc.
  • AbbVie Inc.
  • Lonza Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • Stemline Therapeutics
  • MacroGenics, Inc.
  • OncoMed Pharmaceuticals Inc.
  • STEMCELL Technologies Inc.
  • Irvine Scientificand BIOTIME Inc.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization

 Customization Request

Have a question?

 Speak With Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of Report

 Request Sample
Allied Market Research Allied Market Research Allied Market Research









Purchase Full Report of
Cancer Stem Cells Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers